Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-26 | Barry Quart, Pharm.D. has served as a director of Heron since 2012. Dr. Quart was appointed Chief Executive Officer of the Company in 2013 and President and Chief Executive Officer of the Company in February 2019. ... The following tables and descriptive materials set forth information concerning compensation earned for services rendered to us by our Named Executive Officers during the years ended December 31, 2018, 2017 and 2016. ... Barry Quart, Pharm.D. 2018 Total Compensation: $5,991,297. |
| 2020-04-23 | Barry Quart, Pharm.D. has served as a director of Heron since 2012. Dr. Quart was appointed Chief Executive Officer in 2013 and President and Chief Executive Officer in February 2019. ... Dr. Quart received a Pharm.D. degree from the University of California, San Francisco. ... The following tables and descriptive materials set forth information concerning compensation earned for services rendered to us by our Named Executive Officers during the years ended December 31, 2019, 2018 and 2017. ... Barry Quart, Pharm.D. 2019 Salary $638,991 Option Awards $4,916,373 Non-Equity Incentive Plan Compensation $306,715 All Other Compensation $8,400 Total $5,870,479. |
| 2021-04-22 | Barry Quart, Pharm.D. has served as a director of Heron since 2012. Dr. Quart was appointed Chief Executive Officer in 2013, President and Chief Executive Officer in 2019 and was named Chairman of the Board in October 2020. |
| 2022-04-25 | Barry Quart, Pharm.D. has served as a director of Heron since 2012. Dr. Quart was appointed Chief Executive Officer in 2013, President and Chief Executive Officer in 2019 and was named Chairman of the Board in October 2020. |
Data sourced from SEC filings. Last updated: 2025-12-06